<DOC>
	<DOC>NCT01305525</DOC>
	<brief_summary>This is a prospective non-interventional 24 month post implant registry. Any patient that receives a St. Jude Medical FDA approved implantable neuromodulation system is eligible for enrollment. A minimum of 600 patients will be enrolled from a minimum of 30 sites. Patients will be enrolled post-implant and followed for 24 months. Data are collected at enrollment (within 30 days of device implant), and routine care follow-up visits at 3 months, 6 months, 12 months, 18 months and 24 months.</brief_summary>
	<brief_title>A Prospective Clinical Outcomes Registry</brief_title>
	<detailed_description />
	<criteria>1. Patient has signed and received a copy of the Informed Consent form; 2. Patient has been implanted with a St. Jude Medical Neuromodulation system, including battery and/or SCS leads; 3. Patient is 18 years of age or older. 4. Patient is not currently participating in another clinical trial.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>SCS</keyword>
	<keyword>St. Jude Medical</keyword>
	<keyword>Neuromodulation</keyword>
</DOC>